As of 2016, it manufactured biosimilar drugs, laboratory diagnostic reagents for in vitro use, and recombinant proteins, and exported to other countries in the Middle East and to countries in the Commonwealth of Independent States.
As of 2016, it manufactured medications with similarities to biologics, laboratory diagnostic materials for lab testing, and artificially produced proteins, and exported to countries in the Middle East and those in the Commonwealth of Independent States.